Subhasis Roy

Development of New Localized Drug Delivery System Based on Ceftriaxone-Sulbactam Composite Drug Impregnated Porous Hydroxyapatite: A Systematic Approach for In Vitro and In Vivo Animal Trial

Biswanath Kundu, Chidambaram Soundrapandian, Samit Kumar Nandi et al. · Pharmaceutical Research · 2010 · 91 citations

Tissue Engineering, Engineering, Hydroxyapatite +10

Antidiabetic activity of resveratrol, a known SIRT1 activator in a genetic model for type‐2 diabetes

Sameer Sharma, Chandra Sekhar Misra, Surendar Arumugam et al. · Phytotherapy Research · 2010 · 88 citations

Polyphenolic Sirt1 Activator, Insulin Signaling, Polyphenolics +17

A novel, multi-barrier, drug eluting calcium sulfate/biphasic calcium phosphate biodegradable composite bone cement for treatment of experimental MRSA osteomyelitis in rabbit model

Surajit Mistry, Subhasis Roy, Nilendu Jyoti Maitra et al. · Journal of Controlled Release · 2016 · 49 citations

Tissue Engineering, Regenerative Medicine, Engineering +10

Macro-to-micro porous special bioactive glass and ceftriaxone–sulbactam composite drug delivery system for treatment of chronic osteomyelitis: an investigation through in vitro and in vivo animal trial

Biswanath Kundu, Samit Kumar Nandi, Sudip Dasgupta et al. · Journal of Materials Science Materials in Medicine · 2011 · 48 citations

Orthopaedic Biomaterials, Engineering, Multifunctional Biomaterials +10

Evaluation of hydroxyapatite and β-tri calcium phosphate microplasma spray coated pin intra-medullary for bone repair in a rabbit model

Arjun Dey, Samit Kumar Nandi, Biswanath Kundu et al. · Ceramics International · 2011 · 39 citations

Regenerative Medicine, Tissue Engineering, Synthetic Bone Substitute +9